131 related articles for article (PubMed ID: 38184885)
1. Structure-function relationship study for sulfated protein therapeutics using hydrophobic interaction chromatography and mass spectrometry.
Luo H; Mahon D; Wong P; Madayiputhiya N; Chen Y; Stauffer T; Tao L; Zeng M
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123981. PubMed ID: 38184885
[TBL] [Abstract][Full Text] [Related]
2. Detection of tyrosine sulfation on proteins.
Kanan Y; Al Ubaidi MR
Curr Protoc Protein Sci; 2015 Apr; 80():14.7.1-14.7.20. PubMed ID: 25829299
[TBL] [Abstract][Full Text] [Related]
3. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
Zhang Z; Yan Y; Wang S; Li N
MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
[TBL] [Abstract][Full Text] [Related]
4. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
Stone MJ; Payne RJ
Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
[TBL] [Abstract][Full Text] [Related]
5. Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity.
Lietz CB; Deyanova E; Cho Y; Cordia J; Franc S; Kabro S; Wang S; Mikolon D; Banks DD
MAbs; 2023; 15(1):2259289. PubMed ID: 37742207
[TBL] [Abstract][Full Text] [Related]
6. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
Yan Y; Xing T; Wang S; Daly TJ; Li N
J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
[TBL] [Abstract][Full Text] [Related]
7. High Performance Anion Exchange and Hydrophilic Interaction Liquid Chromatography Approaches for Comprehensive Mass Spectrometry-Based Characterization of the N-Glycome of a Recombinant Human Erythropoietin.
Szabo Z; Thayer JR; Reusch D; Agroskin Y; Viner R; Rohrer J; Patil SP; Krawitzky M; Huhmer A; Avdalovic N; Khan SH; Liu Y; Pohl C
J Proteome Res; 2018 Apr; 17(4):1559-1574. PubMed ID: 29451981
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4.
D'Antona AM; Lee JM; Zhang M; Friedman C; He T; Mosyak L; Bennett E; Lin L; Silverman M; Cometa F; Meade C; Hageman T; Sousa E; Cohen J; Marquette K; Ferguson D; Zhong X
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339208
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.
Seibert C; Cadene M; Sanfiz A; Chait BT; Sakmar TP
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11031-6. PubMed ID: 12169668
[TBL] [Abstract][Full Text] [Related]
10. Revealing the functional roles of tyrosine sulfation using synthetic sulfopeptides and sulfoproteins.
Maxwell JWC; Payne RJ
Curr Opin Chem Biol; 2020 Oct; 58():72-85. PubMed ID: 32777686
[TBL] [Abstract][Full Text] [Related]
11. Native Hydrophobic Interaction Chromatography Hyphenated to Mass Spectrometry for Characterization of Monoclonal Antibody Minor Variants.
Wei B; Han G; Tang J; Sandoval W; Zhang YT
Anal Chem; 2019 Dec; 91(24):15360-15364. PubMed ID: 31747256
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency.
Cai CX; Doria-Rose NA; Schneck NA; Ivleva VB; Tippett B; Shadrick WR; O'Connell S; Cooper JW; Schneiderman Z; Zhang B; Gowetski DB; Blackstock D; Demirji J; Lin BC; Gorman J; Liu T; Li Y; McDermott AB; Kwong PD; Carlton K; Gall JG; Lei QP
Sci Rep; 2022 May; 12(1):8433. PubMed ID: 35589938
[TBL] [Abstract][Full Text] [Related]
13. Exploiting Chemical Protein Synthesis to Study the Role of Tyrosine Sulfation on Anticoagulants from Hematophagous Organisms.
Maxwell JWC; Hawkins PME; Watson EE; Payne RJ
Acc Chem Res; 2023 Oct; 56(19):2688-2699. PubMed ID: 37708351
[TBL] [Abstract][Full Text] [Related]
14. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
[TBL] [Abstract][Full Text] [Related]
15. Characterization of charge variants, including post-translational modifications and proteoforms, of bispecific antigen-binding protein by cation-exchange chromatography coupled to native mass spectrometry.
Shah A; Cui W; Harrahy J; Ivanov AR
Talanta; 2024 Jan; 266(Pt 1):125062. PubMed ID: 37566926
[TBL] [Abstract][Full Text] [Related]
16. Direct identification of tyrosine sulfation by using ultraviolet photodissociation mass spectrometry.
Robinson MR; Moore KL; Brodbelt JS
J Am Soc Mass Spectrom; 2014 Aug; 25(8):1461-71. PubMed ID: 24845354
[TBL] [Abstract][Full Text] [Related]
17. Characterization and prediction of positional 4-hydroxyproline and sulfotyrosine, two post-translational modifications that can occur at substantial levels in CHO cells-expressed biotherapeutics.
Tyshchuk O; Gstöttner C; Funk D; Nicolardi S; Frost S; Klostermann S; Becker T; Jolkver E; Schumacher F; Koller CF; Völger HR; Wuhrer M; Bulau P; Mølhøj M
MAbs; 2019 Oct; 11(7):1219-1232. PubMed ID: 31339437
[TBL] [Abstract][Full Text] [Related]
18. Cysteinylation of a monoclonal antibody leads to its inactivation.
McSherry T; McSherry J; Ozaeta P; Longenecker K; Ramsay C; Fishpaugh J; Allen S
MAbs; 2016; 8(4):718-25. PubMed ID: 27050640
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant monoclonal antibody variants detected by hydrophobic interaction chromatography and imaged capillary isoelectric focusing electrophoresis.
King C; Patel R; Ponniah G; Nowak C; Neill A; Gu Z; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():96-103. PubMed ID: 29649755
[TBL] [Abstract][Full Text] [Related]
20. The structural role of receptor tyrosine sulfation in chemokine recognition.
Ludeman JP; Stone MJ
Br J Pharmacol; 2014 Mar; 171(5):1167-79. PubMed ID: 24116930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
